Treatment Emergent Dolutegravir Resistance Mutations in Individuals Naïve to HIV-1 Integrase Inhibitors: A Rapid Scoping Review by Kaiming Tao, Soo-Yon Rhee, Carolyn Chu, Ava Avalos, Amrit K. Ahluwalia, Ravindra K. Gupta, Michael R. Jordan, Robert W. Shafer

Get full text

Overestimates of survival after HAART: implications for global scale-up efforts. by Gregory P Bisson, Tendani Gaolathe, Robert Gross, Caitlin Rollins, Scarlett Bellamy, Mpho Mogorosi, Ava Avalos, Harvey Friedman, Diana Dickinson, Ian Frank, Ndwapi Ndwapi

Get full text

Five years after Treat All implementation: Botswana’s HIV response and future directions in the era of COVID-19 by Keith Jefferis, Ava Avalos, Heston Phillips, Mpho Mmelesi, Dinah Ramaabya, Bornapate Nkomo, Charles Muthoga, Joseph N. Jarvis, Siphiwe Ratladi, Robert Selato, John Stover

Get full text

Comparison of an in-house 'home-brew' and commercial ViroSeq integrase genotyping assays on HIV-1 subtype C samples. by Kaelo K Seatla, Wonderful T Choga, Mompati Mogwele, Thabo Diphoko, Dorcas Maruapula, Lucy Mupfumi, Rosemary M Musonda, Christopher F Rowley, Ava Avalos, Ishmael Kasvosve, Sikhulile Moyo, Simani Gaseitsiwe

Get full text

Prevalence of Emergent Dolutegravir Resistance Mutations in People Living with HIV: A Rapid Scoping Review by Carolyn Chu, Kaiming Tao, Vinie Kouamou, Ava Avalos, Jake Scott, Philip M. Grant, Soo-Yon Rhee, Suzanne M. McCluskey, Michael R. Jordan, Rebecca L. Morgan, Robert W. Shafer

Get full text

Outcomes of the Botswana national HIV/AIDS treatment programme from 2002 to 2010: a longitudinal analysis by Dr. Mansour Farahani, MD, Anusha Vable, MHP, Refeletswe Lebelonyane, MD, Khumo Seipone, MD, Marina Anderson, MD, Ava Avalos, MD, Tim Chadborn, PhD, Hailu Tilahun, MSc, Danae Roumis, MSc, Themba Moeti, MBBS, Godfrey Musuka, DVM, Lesego Busang, MA, Tendani Gaolathe, MD, Kolaatamo C S Malefho, MD, Prof. Richard Marlink, MD

Get full text